IN8bio, Inc. (INAB)
1.05
+0.06
(+6.50%)
USD |
NASDAQ |
Oct 23, 16:00
1.04
-0.01
(-0.95%)
After-Hours: 20:00
IN8bio Net Income (Quarterly) : -4.781M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.781M |
| March 31, 2026 | -5.09M |
| December 31, 2025 | -4.942M |
| September 30, 2025 | -3.854M |
| June 30, 2025 | -5.094M |
| March 31, 2025 | -5.55M |
| December 31, 2024 | -6.16M |
| September 30, 2024 | -7.086M |
| June 30, 2024 | -8.629M |
| March 31, 2024 | -8.562M |
| December 31, 2023 | -7.598M |
| September 30, 2023 | -7.169M |
| Date | Value |
|---|---|
| June 30, 2023 | -7.715M |
| March 31, 2023 | -7.525M |
| December 31, 2022 | -7.798M |
| September 30, 2022 | -7.399M |
| June 30, 2022 | -7.179M |
| March 31, 2022 | -6.145M |
| December 31, 2021 | -5.849M |
| September 30, 2021 | -3.391M |
| March 31, 2021 | -2.363M |
| September 30, 2020 | -1.681M |
| March 31, 2020 | -1.691M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.781M |
| EPS Diluted (Quarterly) | -0.2456 |
| Enterprise Value | -5.433M |
| Earnings Yield | -177.4% |
| Normalized Earnings Yield | -177.37 |